Published in Clin Exp Metastasis on January 01, 2000
Requirement of cyclooxygenase-2 expression and prostaglandins for human prostate cancer cell invasion. Clin Exp Metastasis (2002) 1.01
COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control (2013) 0.92
Expression of cyclooxygenase-2 in colorectal cancer and its clinical significance. World J Gastroenterol (2005) 0.90
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg (1999) 14.31
Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology (1994) 8.79
Resection of colorectal liver metastases. World J Surg (1995) 7.73
Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell (1998) 7.25
Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell (1995) 6.69
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci U S A (1997) 4.84
Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res (1995) 4.52
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res (2000) 4.18
Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest (1997) 2.99
Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res (1995) 2.74
Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression. Clin Cancer Res (1997) 2.33
The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA (1999) 2.24
Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg (1999) 2.22
Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatology (1999) 2.05
Prostaglandin H synthase 2 is expressed abnormally in human colon cancer: evidence for a transcriptional effect. Proc Natl Acad Sci U S A (1996) 1.88
Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J (1997) 1.50
Anti-inflammatory treatment may prolong survival in undernourished patients with metastatic solid tumors. Cancer Res (1994) 1.50
Size- and invasion-dependent increase in cyclooxygenase 2 levels in human colorectal carcinomas. Cancer Res (1998) 1.46
Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol (2000) 1.42
The role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal antiinflammatory drugs (NSAIDs). J Exp Med (1999) 1.39
Surgery for colorectal cancer metastatic to the liver. Optimizing the results of treatment. Surg Clin North Am (1989) 1.33
The effect of non-steroidal anti-inflammatory drugs on human colorectal cancer cells: evidence of different mechanisms of action. Eur J Cancer (2000) 1.28
Inhibition of haematogenous metastasis of colon cancer in mice by a selective COX-2 inhibitor, JTE-522. Br J Cancer (1999) 1.25
Induction of cyclo-oxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells. Br J Cancer (1997) 1.16
Role of NF-kappaB in the antiproliferative effect of endothelin-1 and tumor necrosis factor-alpha in human hepatic stellate cells. Involvement of cyclooxygenase-2. J Biol Chem (1998) 1.09
Coordinate regulation of cyclooxygenase-2 and TGF-beta1 in replication error-positive colon cancer and azoxymethane-induced rat colonic tumors. Carcinogenesis (1999) 1.07
Distribution of cyclooxygenase-1 and cyclooxygenase-2 mRNAs and proteins in human brain and peripheral organs. Brain Res (1999) 1.07
Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats. Gut (1996) 1.06
Current treatment for colorectal cancer metastatic to the liver. Eur J Surg Oncol (1999) 0.98
Chemoprevention of colorectal cancer through inhibition of cyclooxygenase-2. Semin Oncol (1999) 0.91
Increased expression of cyclooxygenase-2 to -1 in human colorectal cancers and adenomas, but not in hyperplastic polyps. Jpn J Clin Oncol (1998) 0.91
Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet (1994) 5.86
Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States. Int J Tuberc Lung Dis (2013) 3.08
Risk of neoplasia in renal transplant patients. Lancet (1995) 2.65
Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol (2007) 2.42
Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg (2008) 2.38
Neonatal pulmonary hypertension--urea-cycle intermediates, nitric oxide production, and carbamoyl-phosphate synthetase function. N Engl J Med (2001) 2.16
Fluorescence determinatioof sub-parts per billion hydrogen sulfide in the atmosphere. Anal Chem (1969) 2.03
Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. Health Technol Assess (2004) 1.82
A prospective randomized trial of day-stay only versus overnight-stay laparoscopic cholecystectomy. Aust N Z J Surg (1999) 1.82
Effect of specialist decision-making on treatment strategies for colorectal liver metastases. Br J Surg (2012) 1.67
Pneumothorax, pneumomediastinum, pneumoperitoneum, pneumoretroperitoneum and subcutaneous emphysema following diagnostic colonoscopy. Ann R Coll Surg Engl (2007) 1.66
Fatty liver disease as a predictor of local recurrence following resection of colorectal liver metastases. Br J Surg (2013) 1.62
Are differences in stage at presentation a credible explanation for reported differences in the survival of patients with colorectal cancer in Europe? Br J Cancer (2001) 1.58
Oxygen free radicals and congestive heart failure. Br Heart J (1991) 1.55
Omega-3 polyunsaturated fatty acids for the treatment and prevention of colorectal cancer. Gut (2011) 1.54
Prognostic influence of multiple hepatic metastases from colorectal cancer. Eur J Surg Oncol (2006) 1.53
Cholecystectomy-related bile duct and vasculobiliary injuries. Br J Surg (2012) 1.52
Further evidence of increased polymorphonuclear cell activity in patients with Raynaud's phenomenon. Br J Rheumatol (1992) 1.50
Immunohistochemical detection of the anti-apoptosis protein, survivin, predicts survival after curative resection of stage II colorectal carcinomas. Ann Surg Oncol (2001) 1.48
Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology (1993) 1.45
Localization of cyclooxygenase-2 in human sporadic colorectal adenomas. Am J Pathol (2000) 1.42
Radiotherapy and rectal cancer. J Pathol (2002) 1.40
Non-operative management of pyogenic liver abscess. HPB (Oxford) (2003) 1.26
Inflammatory pseudotumours of the liver: a spectrum of presentation and management options. Eur J Surg Oncol (2009) 1.25
Resection margin in patients undergoing hepatectomy for colorectal liver metastasis: a critical appraisal of the 1cm rule. Eur J Surg Oncol (2006) 1.23
Cyclooxygenase 2 is up-regulated and localized to macrophages in the intestine of Min mice. Br J Cancer (1999) 1.22
What factors affect lymph node yield in surgery for rectal cancer? Colorectal Dis (2004) 1.21
C-reactive protein as a predictor of prognosis following curative resection for colorectal liver metastases. Br J Cancer (2007) 1.21
Steatosis predicts postoperative morbidity following hepatic resection for colorectal metastasis. Br J Surg (2007) 1.19
Captopril: a free radical scavenger. Br J Clin Pharmacol (1989) 1.16
Does self-monitoring of blood glucose levels improve dietary compliance for obese patients with type II diabetes? Am J Med (1986) 1.12
The influence of invasive growth pattern and microvessel density on prognosis in colorectal cancer and colorectal liver metastases. Br J Cancer (2007) 1.10
The impact of spontaneous tumour perforation on outcome following colon cancer surgery. Colorectal Dis (2008) 1.09
Surgery for hilar cholangiocarcinoma: the Leeds experience. Eur J Surg Oncol (2007) 1.09
The psychopharmacological and electrophysiological effects of single doses of caffeine in healthy human subjects. Br J Clin Pharmacol (1986) 1.08
Operation Everest II: alterations in the immune system at high altitudes. J Clin Immunol (1988) 1.07
Mirizzi's syndrome--results from a large western experience. HPB (Oxford) (2006) 1.07
Helicobacter gastritis and intestinal metaplasia in a gastric cancer family. Lancet (1990) 1.05
'Patientspeak': an exercise in communication. J Med Educ (1984) 1.03
Predictors of early disease recurrence following hepatic resection for colorectal cancer metastasis. Eur J Surg Oncol (2007) 1.02
A 6-Mb high-resolution physical and transcription map encompassing the hereditary prostate cancer 1 (HPC1) region. Genomics (2000) 1.01
The risk of gallbladder cancer from polyps in a large multiethnic series. Eur J Surg Oncol (2008) 1.01
Microwave ablation with or without resection for colorectal liver metastases. Eur J Surg Oncol (2013) 1.00
Biliary strictures complicating pancreaticoduodenectomy. Int J Pancreatol (2000) 0.99
Effect of type of resection on outcome of hepatic resection for colorectal metastases. Br J Surg (2007) 0.96
Reperfusion injury, antioxidants and hemodynamics during orthotopic liver transplantation. Hepatology (1994) 0.96
Heterotopic gastric mucosa presenting as small-bowel obstruction. Br J Radiol (1987) 0.95
Hepatic cystic disease in an adult polycystic kidney disease transplant population. Aust N Z J Surg (1996) 0.95
The role of hypoxia in recurrence following resection of Dukes' B colorectal cancer. Int J Colorectal Dis (2008) 0.95
Epidural analgesia and liver resection: postoperative coagulation disorders and epidural catheter removal. Minerva Anestesiol (2008) 0.95
Systematic review and meta-analysis of follow-up after hepatectomy for colorectal liver metastases. Br J Surg (2012) 0.94
Liver transplantation for metastatic hemangiopericytoma associated with hypoglycemia. Transplantation (1999) 0.93
Breast imaging findings in women with BRCA1- and BRCA2-associated breast carcinoma. Clin Radiol (2004) 0.92
p53 but not bcl-2 is expressed by most cholangiocarcinomas: a study of 28 cases. Histopathology (1999) 0.92
Management of blunt liver trauma in a tertiary referral centre. Br J Surg (2004) 0.92
Cardiorenal endocrine dynamics during volume expansion in hypothyroid dogs. Am J Physiol (1988) 0.92
Association of thymidylate synthase enhancer region polymorphisms with thymidylate synthase activity in vivo. Pharmacogenomics J (2010) 0.92
The role of (99m)technetium-labelled hepato imino diacetic acid (HIDA) scan in the management of biliary pain. HPB (Oxford) (2007) 0.91
Transplant renal artery aneurysm following venous patch repair of a traction injury to the renal artery. Nephrol Dial Transplant (1998) 0.91
Repeat hepatic resection for colorectal liver metastases. Br J Surg (2012) 0.91
Preliminary evaluation of a Low-Cost VideoConferencing (LCVC) system for remote cognitive testing of adult psychiatric patients. Br J Clin Psychol (1993) 0.90
Outcomes of intensive surveillance after resection of hepatic colorectal metastases. Br J Surg (2010) 0.89
Caffeine withdrawal symptoms and rate of metabolism. J Psychopharmacol (1996) 0.89
Bilateral knee replacements: simultaneous or staged? J R Coll Surg Edinb (1993) 0.89
Outcome following repeat liver resection for colorectal liver metastases. Eur J Surg Oncol (2007) 0.88
Yellow nail syndrome associated with empyema. Clin Exp Dermatol (1989) 0.88
Expression patterns of hypoxic markers at the invasive margin of colorectal cancers and liver metastases. Eur J Surg Oncol (2009) 0.88
Perioperative chemotherapy for resectable colorectal liver metastases: where now? Eur J Surg Oncol (2013) 0.87
Treatment of metastatic Vipoma by liver transplantation. Clin Transplant (1990) 0.87
In-contiguity and non-anatomical extension of right hepatic trisectionectomy for liver metastases. Br J Surg (2005) 0.87
Neuropeptide Y and neuropeptide Y18-36. Structural and biological characterization. Int J Pept Protein Res (1989) 0.87
Systemic cytomegalovirus infection complicating ulcerative colitis: a case report and review of the literature. Postgrad Med J (2004) 0.85
Control of fecal incontinence: continued success with the Malone procedure. Surgery (1997) 0.85
Cost-utility analysis of operative versus non-operative treatment for colorectal liver metastases. Br J Surg (2015) 0.84
Are medullary breast cancers an indication for BRCA1 mutation screening? A mutation analysis of 42 cases of medullary breast cancer. Breast Cancer Res Treat (2004) 0.84
Enhanced preservation of the auditory nerve following cochlear perfusion with nerve growth factors. Am J Otol (1995) 0.84
Variation in referral practice for patients with colorectal cancer liver metastases. Br J Surg (2013) 0.84
The Liverpool uveal melanoma liver metastases pathway: outcome following liver resection. J Surg Oncol (2013) 0.83
Differential CD74 (major histocompatibility complex Class II invariant chain) expression in mouse and human intestinal adenomas. Eur J Cancer (2009) 0.83
Extracellular matrix proteins and chemoradiotherapy: alpha5beta1 integrin as a predictive marker in rectal cancer. Eur J Surg Oncol (2002) 0.83
Right lower lobe consolidation: an unusual complication of the modified Blalock-Taussig operation. Ann Thorac Surg (1987) 0.83
Oxidative damage in chronic heart failure: protection by captopril through free radical scavenging? Adv Exp Med Biol (1990) 0.83
Anxiogenic effects of caffeine in patients with anxiety disorders. Arch Gen Psychiatry (1992) 0.83
Preoperative determinants of common bile duct stones during laparoscopic cholecystectomy. Int J Clin Pract (2007) 0.83
The impact of caudate lobe involvement after hepatic resection for colorectal metastases. Eur J Surg Oncol (2008) 0.82
A critical appraisal of the role of neoadjuvant chemotherapy for colorectal liver metastases: a case-controlled study. Ann Surg Oncol (2007) 0.82
Circadian rhythm of white blood cell aggregation and free radical status in healthy volunteers. Free Radic Res Commun (1992) 0.82
Aggressive surgical resection for the management of hepatic metastases from gastrointestinal stromal tumours: a single centre experience. HPB (Oxford) (2007) 0.82
Further observations on spermiophagy by murine peritoneal macrophages in vitro. J Reprod Fertil (1984) 0.82
Hepatic resection for metastatic gastrointestinal and pancreatic neuroendocrine tumours: outcome and prognostic predictors. HPB (Oxford) (2007) 0.82
Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI(®)) for colorectal liver metastases does not predict tumour destruction or long-term outcome. Eur J Surg Oncol (2013) 0.82
Intermittent Pringle manoeuvre is not associated with adverse long-term prognosis after resection for colorectal liver metastases. Br J Surg (2008) 0.81
Secondary malignant synovitis: report of three cases and review of the literature. Q J Med (1984) 0.81
The impact of postoperative infection on long-term outcomes in liver transplantation. Transplant Proc (2010) 0.81
Pharmacokinetics and safety of oral eletriptan during different phases of the menstrual cycle in healthy volunteers. J Clin Pharmacol (2001) 0.81
Manometric asymmetry in the anal canal in controls and patients with fecal incontinence. Dis Colon Rectum (1995) 0.81